Phase II study of gefitinib in patients with advanced salivary gland cancers.
Saved in:
| Title: | Phase II study of gefitinib in patients with advanced salivary gland cancers. |
|---|---|
| Authors: | Jakob JA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology/Medical Oncology Division, Northeast Ohio Medical University, Medina, Ohio., Kies MS, Glisson BS, Kupferman ME, Liu DD, Lee JJ, El-Naggar AK, Gonzalez-Angulo AM, Blumenschein GR Jr |
| Source: | Head & neck [Head Neck] 2015 May; Vol. 37 (5), pp. 644-9. Date of Electronic Publication: 2015 Mar 30. |
| Publication Type: | Clinical Trial, Phase II; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley And Sons Country of Publication: United States NLM ID: 8902541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0347 (Electronic) Linking ISSN: 10433074 NLM ISO Abbreviation: Head Neck Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
